Further study found that RSF1 overexpression in nasopharyngeal carcinoma CEN-2 cells increases the expression of the NF-κB targeted gene SURVIVIN, thereby enhancing paclitaxel resistance by activating NF-κB [88]. This evidence concerns the gene NFKB1 and nasopharyngeal carcinoma.